Madrigal Pharmaceuticals, Inc. - Common Stock — キャッシュフロー (NASDAQ:MDGL) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

営業活動によるキャッシュフロー -157.56 M-183.92 M-224.86 M-324.23 M-455.57 M-189.55 M -268.1 M 投資活動によるキャッシュフロー 159.78 M-5.05 M206.69 M-502.52 M-274.39 M32.32 M 60.63 M 財務活動によるキャッシュフロー 5.09 M171.24 M313.45 M595.12 M735.06 M255.98 M 249.67 M フリーキャッシュフロー -157.56 M-183.92 M-224.86 M-324.23 M-455.57 M-193.02 M -275.41 M

ニュース

Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up

Madrigal (MDGL) Reports Q1 Loss, Beats Revenue Estimates

Analysts Estimate Crinetics Pharmaceuticals, Inc. (CRNX) to Report a Decline in Earnings: What to Look Out for

Madrigal (MDGL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Altimmune Catalysts: 2026 Data Readouts and Financing Risks

ALT Stock: What Pemvidutide Means for MASH, AUD and ALD

Is Altimmune a Buy Before Phase III MASH Starts in 2026?

United Therapeutics (UTHR) Up 5.7% Since Last Earnings Report: Can It Continue?

Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?

Why Is Corcept (CORT) Up 11.7% Since Last Earnings Report?

ALT Stock and the 2026 MASH Race: Dual Agonists vs. New Mechanisms

ALT Pemvidutide Explained: What Makes It Different in MASH